China / 产品区域 / 介入通路 / 急性血液透析

急性血液透析

急性血液透析

泰利福提供丰富的急性血液透析和大孔导管（带或不带 ARROWg+ard 抗微生物技术）。临床研究表明，ARROWg+ard 抗微生物技术能够减少与导管有关的血流感染 1。它能减少 44% 的细菌定植和 79% 的与导管造成的菌血症2。

参考：


1. Veenstra, D.L., Saint, S., Saha, S., Lumley, T., Sullivan, S.D. “Cost-Effectiveness of Antiseptic-Impregnated Central Venous Catheters for the Prevention of Catheter-Related Bloodstream Infection.” Journal of the American Medical Association, January 20, 1999, Vol. 281, Issue 3, pp. 261–267.
2. Maki, D.G., Stolz, S.M., Wheeler, S., Mermel, L.A. “Prevention of Central Venous Catheter-Related Bloodstream Infection With an Antiseptic-Impregnated Catheter: A Randomized, Controlled Trial.” Annals of Internal Medicine, August 15, 1997, Vol. 127, Issue 4, pp. 257–266.